Abstract PS08-09: Impact of HER2 expression dynamics on the real-world activity of trastuzumab deruxtecan for metastatic breast cancer (RELIEVE)Paolo Tarantino, Sara M. Tolaney, Alyssa Pereslete et al.|Cancer Research|2024Cited by 11
Brain metastasis as the first and only metastatic relapse site portends worse survival in patients with advanced HER2 + breast cancerLaura Noteware, Sarah Sammons, Gloria Broadwater et al.|Breast Cancer Research and Treatment|2022Cited by 6